We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01088737
Recruitment Status : Active, not recruiting
First Posted : March 17, 2010
Last Update Posted : October 30, 2017
Sponsor:
Information provided by (Responsible Party):
Peter Wolf, MD, Medical University of Graz

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : December 2021